Rising prostate-specific antigen after local therapies have failed: an urgent need for more information.
Sartor
Oliver
O
D000726:Androgen Antagonists / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood*; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D008991:Monitoring, Physiologic / Q000379:methods; D009367:Neoplasm Staging; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000473:pathology / Q000628:therapy*; D011878:Radiotherapy / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D017211:Treatment Failure
D000726:Androgen Antagonists; D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen